Further exploration using Jab1 siRNA in AML cells revealed that the decrease in phosphorylated Akt was induced by Jab1 reduction, with this effect being further intensified by additional treatment with either AZA or Ara-C [4](Figure 4D). Here, AKT1 is linked to acute myeloid leukemia.